| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |